ARCHIVES

Genentech: ODAC Lacks Expertise, Impartiality; FDA: Company’s Proposal Unscientific

This article is from The Cancer Letter archive.

Vol. 37 No. 32 | August 12, 2011

Download PDF Visit The Full Archive

Related Articles

NCI Launches ALCHEMIST

September 5, 2014

DCT Board Okays Recompetition of $15 Million In contract Projects

November 10, 1978

Senate Committee Proposes $301 Million Increase For NIH

September 22, 1995

DCBD Board Like Organ Systems Program But Not RFAs, Okays Program Announcement, Contract Concepts

November 20, 1987

ACCC Committee Hears Alternative Ways To Do Clinical Trials In Community

May 8, 1981

Oncogens Variations May Exaplin Susceptibility, Familial Cancer, USC Investigators Report

September 23, 1988